DRUG · Mapped RxNorm record
Setmelanotide
Normalized identity: setmelanotideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
NCT01749137
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPhase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Overweightunresolved
Interventions
SetmelanotideDRUG · verified · RxNorm: setmelanotide
PlaceboDRUG
Sponsors & collaborators
Rhythm Pharmaceuticals, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01749137 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.